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Gérard Pierron7, Sylvie Lachkar1,2,3,4,5, Allan Sauvat1,2,3,4,5, Adriana Petrazzuolo1,2,3,4,5, Ana Joaquina Jimenez8,
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Abstract
The retention using selective hooks (RUSH) system allows to retain a target protein fused to green ﬂuorescent protein
(GFP) and a streptavidin-binding peptide (SBP) due to the interaction with a molar excess of streptavidin molecules
(“hooks”) targeted to selected subcellular compartments. Supplementation of biotin competitively disrupts the
interaction between the SBP moiety and streptavidin, liberating the chimeric target protein from its hooks, while
addition of avidin causes the removal of biotin from the system and reestablishes the interaction. Based on this
principle, we engineered two chimeric proteins involved in autophagy, namely microtubule-associated proteins 1A/1B
light chain 3B (MAP1LC3B, best known as LC3) and sequestosome-1 (SQSTM1, best known as p62) to move them as
SBP–GFP–LC3 and p62–SBP–GFP at will between the cytosol and two different organelles, the endoplasmic reticulum
(ER) and the Golgi apparatus. Although both proteins were functional in thus far that SBP–GFP–LC3 and p62–SBP–GFP
could recruit their endogenous binding partners, p62 and LC3, respectively, their enforced relocation to the ER or
Golgi failed to induce organelle-speciﬁc autophagy. Hence, artiﬁcial tethering of LC3 or p62 to the surface of the ER
and the Golgi is not sufﬁcient to trigger autophagy.
Introduction
Macroautophagy (hitherto called “autophagy”) is the
sole mechanism allowing for the turnover of entire
organelles and large protein aggregates, hence having a
major role in cellular adaptation to stress and changing
conditions, as well as in the avoidance of premature aging
of cytoplasmic components. For this reason, deregulated
autophagy is connected to multiple different diseases,
spurring interest in the in-depth characterization of this
cell biological phenomenon1–4.
The regulation of autophagy is complex involving the
coordinated activation of protein kinases (in particular
the ULK1 kinase complex), lipid kinases (in particular the
Beclin 1 complex) and a ubiquitin-like conjugation system
(organized around ATG5 and ATG7)5,6. This latter sys-
tem assures the C-terminal lipidation (by the attachment
of a phosphatidyl ethanolamine group) of proteolytically
matured proteins from the microtubule-associated pro-
teins 1 A/1B light chain 3B (hereafter referred to as LC3)
family (such as LC3A, LC3B, or GABARAP), hence
increasing their lipophilicity and allowing them to insert
into the membrane of nascent phagophores (that engulf
autophagic cargo), autophagosomes (that have closed to
sequester the cargo) and autolysosomes (that arise from
the fusion of autophagosomes with lysosomes)7,8. Indeed,
many assays designed to quantify autophagy monitor the
lipidation of LC3 (which increases its electrophoretic
mobility) and the subcellular distribution of LC3 toward
cytoplasmic “puncta”9.
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Indeed, LC3 and its analogues play a major role both in
general autophagy (when there is no selectivity for speciﬁc
cargo) and in selective autophagy9. Typically, cargo, which
often is ﬂagged for destruction by ubiquitin tags, can
interact with LC3 tethered to autophagy-relevant endo-
membranes via adapters or receptors10–12. Although
multiple distinct adapters have been identiﬁed, the best-
characterized one is sequestosome 1 (SQSTM1, best
known as p62). This protein binds to LC3 by virtue of its
LC3-interacting region (LIR) and can simultaneously
recognize (often polyubiquitinylated) proteins, thus
forming an adapter between LC3-decorated nascent
autophagosomes and proteins or organelles that have
been “marked” for degradation13,14. This function of p62
as an autophagic adapter and substrate is so important
that increased autophagic ﬂux is usually accompanied by
the cellular depletion of p62, implying that a reduction in
the abundance of p62 is usually interpreted as a sign of
autophagy9.
General autophagy can be induced by nutrient
depletion, pharmacological modulation of nutrient
sensors (such as activation of AMP activated kinase,
AMPK, or inhibition of either mechanistic target of
rapamycin complex 1, mTORC1, or the acetyltransfer-
ase EP300) or by genetic means15,16. For example,
transgenic overexpression of the autophagy gene ATG5
or a gain-of-function mutation of Beclin 1 are sufﬁcient
to increase autophagic ﬂux in mice and to increase their
lifespan17,18. However, there are no experimental sys-
tems to reversibly stimulate autophagy by means of
chemically regulated genetic modiﬁcations apart from
the tetracycline-inducible induction of autophagy-
related gene such as ATG519,20. Here, we explored the
possibility to create an experimental system in which
major autophagy-relevant proteins such as LC3 and p62
are forced to reversibly interact with deﬁned subcellular
structures, hoping that such a manipulation might
induce selective autophagy at will. For this, we took
advantage of the retention using selective hooks (RUSH)
system, consisting in the expression of organelle-
targeted streptavidin protein (the “hook”), normally
cytosolic proteins containing a streptavidin-binding
peptide (SBP) as “baits”, and the modulation of the
streptavidin–SBP interaction by varying the intracellular
concentration of the small molecule biotin. Indeed,
biotin can outcompete hook–bait interactions, meaning
that increasing its concentration separates the hook
from the bait, while depleting biotin (for instance by
adding its scavenger avidin) favors the binding of the
bait to the hook21,22. Here, we show that this system can
be used to successfully enforce the subcellular shuttling
of functional LC3 and p62, yet fails to stimulate bona
ﬁde autophagy.
Results
A two-component chemical–biological system to target
LC3 or p62 to organelles
Streptavidin is known to bind to biotin or proteins con-
taining a SBP with femtomolar and nanomolar afﬁnity,
respectively23,24. Based on these physicochemical properties,
we built a two-component RUSH system21, in which
streptavidin is located to different subcellular compartments
by fusing it with CD74 (that is usually located in the
endoplasmic reticulum, ER) or Golgin84 (which resides in
the Golgi apparatus) (Fig. 1a). When stably transfected into
human osteosarcoma U2OS cells, the streptavidin–CD74
construct (the “ER hook”) and the streptavidin–golgin84
construct (the “Golgi hook”) were correctly expressed in
their target organelles, as demonstrated by co-staining with
the endogenous ER protein calreticulin (CALR) or the
endogenous Golgi protein B4GALT1 (Fig. 1b, c). We also
generated gene constructs that contain an SBP, a green
ﬂuorescent protein (GFP) moiety and either microtubule-
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Fig. 1 Streptavidin fusion transgenes are correctly localized to
target organelles. a Scheme depicting the constructs targeting
streptavidin to the ER (CD74) or Golgi (Golgin84). b Immunoﬂuorescence
staining showing localization of transgenes in cell lines stably expressing
Streptavidin-CD74 (ER hook) and Streptavidin–Golgin84 (Golgi hook).
Streptavidin staining is depicted in orange, CALR staining as marker for
ER and B4GALT1 staining as marker for Golgi are in red. Scale bar equals
10 µm. c Quantiﬁcation of relative co-occupancy of streptavidin
immunoﬂuorescence signal with CALR/B4GALT1 immunoﬂuorescence
signal as compared to Hoechst 33342 with CALR/B4GALT1
immunoﬂuorescence staining. Bars indicate means ± standard deviation
of at least three replicates (*p< 0.05 and **p< 0.01, two-tailed Student’s
t test, compared to control cells)
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associated proteins 1 light chain 3B (MAP1LC3B, best
known as LC3) or sequestosome 1 (SQSTM1, best known as
p62) in an order of domains that assures their correct sub-
cellular localization and function25,26 (Fig. 2a). Indeed, the
SBP–GFP–LC3 fusion protein usually distributed through-
out the cell in a diffuse fashion and move to cytoplasmic
puncta upon treatment with the autophagy inducer rapa-
mycin (Fig. 2b, c). Moreover, p62–SBP–GFP was reduced in
its expression level upon autophagy induction by rapamycin,
causing a decrease in the average GFP ﬂuorescence intensity.
This reduction was blocked if rapamycin was combined with
the lysosomal inhibitor baﬁlomycin A1 (BafA1), which
instead caused p62–SBP–GFP to accumulate in puncta (Fig.
2b–d). In the next step, we created four cell lines in which
the ER- and Golgi hooks each were combined with two
different “baits”, SBP–GFP–LC3 or p62–SBP–GFP. We
reasoned that in the presence of biotin, the molecular
interaction between the hooks and baits (which is mediated
by comparatively low-afﬁnity interactions between the
streptavidin and SBP domains) should be competitively
disrupted (because of the high-afﬁnity interaction between
streptavidin and biotin) and that addition of excess avidin
into the system (which can be added in soluble form to the
culture media and gradually attracts biotin from the inter-
cellular to the extracellular compartment) should then allow
for re-establishing the docking of hooks and baits (Fig. 3a).
Indeed, the addition of biotin to the system caused a sub-
stantial release of SBP–GFP–LC3 or p62–SBP–GFP from
the ER or Golgi hooks, while supplementation of the cells
with avidin enforced the redistribution of the
SBP–GFP–LC3 or p62–SBP–GFP baits to their ER or Golgi
hooks (Fig. 3b–e). Of note, rapamycin alone failed to sti-
mulate the colocalization of baits and hooks and also did not
interfere with the avidin-stimulated colocalization (Supple-
mentary Fig. 1). Altogether, these results demonstrate the
feasibility of constructing a two-component, hook-bait sys-
tem that is modulated by pharmacological modulators, thus
constituting a chemical-biological toolkit to reversibly tether
LC3 or p62 to different target organelles.
ER or Golgi-targeted LC3 and p62 attract their binding
partners
Although we have shown that SBP–GFP–LC3 or
p62–SBP–GFP behave like endogenous LC3 or p62 upon
autophagy induction by rapamycin, the ﬁrst distributing to
cytoplasmic puncta (which correspond to autophago-
somes)25, the second reducing its abundance (which reﬂects
autophagic ﬂux)27 (see above Fig. 2), one might argue that
these fusion proteins might have changed their native
conformation, hence losing the capacity to interact among
each other via the LIR in p629. We therefore transduced the
two cell lines harboring p62–SBP–GFP in the context of
either an ER–hook or a Golgi–hook with a lentivirus-
encoded red ﬂuorescent protein (RFP)–LC3 substrate. In
this context, addition of avidin did not only cause the
redistribution of p62–SBP–GFP toward ER or Golgi, but
also triggered the recruitment of RFP–LC3 to
p62–SBP–GFP, meaning that the two proteins colocalized
(Fig. 4a–d). Similarly, immunostaining of endogenous p62
protein revealed that it redistributed to the areas of the cells
that accumulated SBP–GFP–LC3 upon avidin treatment as
a function of the streptavidin hook present in the ER or in
the Golgi (Fig. 4a–d). These results indicate that LC3 within
SBP–GFP–LC3 and p62 within p62–SBP–GFP conserved
their capacity to bind to p62 and LC3, respectively.
Failure of ER or Golgi-targeted LC3 and p62 to stimulate
autophagy
In the next step, we wondered whether artiﬁcially
moving LC3 or p62 to the ER or the Golgi by means of
chemical–biological tools would be sufﬁcient to sti-
mulate organelle-speciﬁc autophagy. For this, we
Hoechst Hoechst
SBP GFP LC3
p62 SBP GFP
pCDH
Hygro
SBP-GFP-LC3 p62-SBP-GFP
SBP-GFP-LC3 p62-SBP-GFP
R
ap
a
C
trl
R
ap
a 
+ 
B
af
A
1
C D
BA
0
1.0
0.5
1.5
2.0
0
5
10
15
20
**
***
G
FP
+  p
un
ct
a/
ce
ll
*
p62-SBP-GFP
0
200
100
*
R
el
. G
FP
 fl
uo
. i
nt
en
s.
Ctrl Rapa
BafA1
Ctrl Rapa
BafA1
Ctrl Rapa
Fig. 2 LC3 and p62 bait constructs behave normally. a Scheme
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cultured cells for up to 48 h in the presence of either
biotin (to inhibit the interaction between the hooks and
the baits) or avidin (to allow this interaction), followed
by quantitation of the abundance of quintessential ER
and Golgi proteins such as CALR and B4GALT1,
respectively. This quantitation was performed either by
immunoﬂuorescence (Fig. 5a–d, Supplementary Fig. 2)
or immunoblot (Fig. 5e–h). Of note, avidin alone failed
to cause a reduction in the abundance of ER and Golgi
markers (Fig. 5a–g) or to reduce the dimension of the
organelles (Supplementary Fig. 2) as compared to
biotin-treated controls. In contrast, the positive control
(rapamycin) was able to reduce the abundance of
B4GALT1 in the cells (Fig. 5f, h). Moreover, confocal
ﬂuorescence microscopy failed to reveal any signiﬁcant
colocalization between the targeted organelles and the
lysosome-associated membrane protein-1 (LAMP1),
both in the presence and in the absence of rapamycin
(Fig. 6). Moreover, immunogold staining revealed the
avidin-induced presence of SBP–GFP–LC3 on single-
membraned rather than double-membraned structures
(Fig. S3). We conclude from this that enforcing the
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movement of LC3 or p62 to speciﬁc organelles is not
sufﬁcient to trigger the autophagic cascade.
Discussion
Here, we report the development of a chemical–biological
tool kit allowing to target GFP- and SBP-tagged LC3 or p62
(the “baits”) to distinct subcellular locations such as the ER
and the Golgi decorated with streptavidin moieties (the
“hooks”). Movement of the baits within the cells was
induced by either biotin (to competitively disrupt the
interaction) or avidin (which neutralizes biotin). As to be
expected, GFP/SBP-tagged LC3 targeted to ER or the Golgi
upon addition of avidin was able to interact with endo-
genous p62 protein, and, similarly, GFP/SBP-tagged p62
could drag endogenous LC3 protein to the compartment it
had been destined to. Hence, in spite of the GFP/SBP tag,
both chimeric proteins appeared to be functional with
respect to their capacity to interact with their endogenous
binding partners. Notwithstanding this fact, the enforced
movement of GFP/SBP-tagged LC3 or p62 toward the ER
or the Golgi failed to trigger autophagy as indicated by
several lines of evidence: (i) the absence of the formation of
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(by deﬁnition) two-membraned autophagosomes dis-
cernible by electron microcopy, (ii) no recruitment of
lysosomes toward the target organ, and (iii) no reduction in
the overall abundance of ER and Golgi (as this would have
to be expected if these organelles were destroyed by
autophagy28,29).
The failure of the enforced recruitment of LC3 or p62 to
ER or Golgi to induce full-blown autophagy appears
unexpected. As a possibility, additional input from con-
verging autophagy-stimulatory pathways (like the ULK1/
ULK2 protein kinase, the Beclin 1/PIK3C3 lipid kinase
complex or the ATG5/7/10/12 conjugation system) may
be obligatory to set off the cascade leading to autophagy30.
Thus, failure to coordinately activate these pro-
autophagic signal transducers might result in the
absence of autophagy. In other words, it is possible that
the forced (unnatural) tethering of LC3 or p62 to the
single-membraned surface of the ER and the Golgi occurs
in a non-physiological setting, not resembling the initial
steps of selective autophagy.
That said, there are multiple instances in which endo-
genous LC3 and p62 are recruited to the Golgi while not
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inducing full-blown autophagy, as indicated by (i) the
absence of two-membraned autophagosomes, the (ii) the
absence of the implication of ULK1/ULK2 and Beclin 1/
PIK3C3, and (iii) no signs of selective Golgi-phagy. This
applies to damage of the Golgi apparatus by (i) localized
laser damage inﬂicted by means of confocal microscopy,
(ii) Golgi-targeted expression of peroxidase and treatment
with H2O2 and the chemical diaminobenzidine, (iii)
addition of the Golgi-tropic photosensitizer redaporﬁn
followed by administration of blue light, (iv) treatment
with the Golgi-tropic anticancer peptidomimetic LTX-
401, and (v) exposure to high doses of cis-unsaturated
fatty acids31. In all these cases, LC3 and p62 are recruited
to the Golgi in the absence of conventional autophagy. In
sharp contrast, there are multiple examples how ER stress
leads to selective removal of portions of the ER, a process
that has been nicknamed “ER-phagy”28,29,32or “reticulo-
phagy”33. Thus, while it might be plausible that the Golgi
is endowed with some mechanism to avoid its autophagic
removal (and indeed reports on “Golgi-phagy” are rare)
there is probably no such mechanism for the ER (and ER-
associated protein have been reported as autophagic
substrates)34,35. Hence, we favor the hypothesis that it is
the intrinsic incapacity of single-membrane-tethered LC3
or p62 to ignite the autophagic cascade rather than an
active inhibitory mechanism emanating from the ER/
Golgi compartment that explains the failure of this
chemical–biological approach to stimulate selective
removal of organelles.
In spite of these shortcomings, the present report
demonstrates the feasibility to move proteins from one to
another subcellular localization at will. By simply aug-
menting or reducing the intracellular concentration of
free biotin, it is possible to trigger the reversible move-
ment of engineered proteins from the cytosol to target
organelles.
Materials and methods
Cell culture, reagents, and antibodies
Human osteosarcoma U2OS cells were cultured in
Dulbecco’s Modiﬁed Eagle Medium supplemented with
10% fetal bovine serum, 100 U/mL penicillin, 100 μg/mL
streptomycin, and 10mM HEPES in a humidiﬁed atmo-
sphere containing 5% CO2 at 37 °C. Cell culture media
and supplements were from Gibco-Invitrogen (Carlsbad,
CA, USA), and all plastic supplies from Corning (Corning,
NY, USA).
Geneticin (Neo) and hygromycin (Hygro) were pur-
chased from Invivogen (San Diego, CA, USA). Biotin and
avidin were purchased from Sigma-Aldrich (St. Louis, MI,
USA). Rapamycin and baﬁlomycin A1 were purchased
from LC Laboratories (Woburn, MA, USA).
Primary antibodies used in this study are: rabbit anti-
GAPDH (#2118, Cell Signaling Technology), rabbit anti-
B4GALT1 (PAB20512, Abnova), rabbit anti-CALR
(ab2907, Abcam), mouse anti-streptavidin (sc-52234,
Santa Cruz), mouse anti-SQSTM1 (sc-28359, Santa Cruz).
Secondary antibodies used in this study are from South-
ern Biotech (HRP-conjugated; Birmingham, AL, USA) or
Thermo Fisher Scientiﬁc-Molecular Probes (Alexa 488-,
Alexa 546- or Alexa 647-conjugated; Waltham,
MA, USA).
Plasmid construction
To generate reporter plasmids, the secretory signal of
pCDH-ss-SBP-EGFP21 was removed by site-directed
mutagenesis with Agilent QuikChange Lightning (Santa
Clara, CA, USA) according to manufacturer’s instructions
(primers 5′-ATCCGGCGCGCCATGAATTCCGACGA
GAAG-3′ and 5′-CTTCTCGTCGGAATTCATGGCGCG
CCGGAT-3′), yielding pCDH-SBP-EGFP. SQSTM1 (p62)
ampliﬁed from p62-HT (26; primers 5′-TAAGCTAGC
CATGGCCATGT-CCTACGTGAAG-3′ and 5′-TAAGG
CGCGCCTCAACGGCGGGGGATGCTTT-3′) and LC3
ampliﬁed from GFP-LC3 (25; primers 5′- TAAGGC
CGGCCAAGACCGTCCGAGAAG-ACCTT-3′ and 5′-
TAAGCGGCCGCTCACAAGCATGGCTCTCTTCC-3′)
were ligated with NheI/AscI and FseI/NotI, respectively,
into pCDH-SBP-EGFP, yielding pCDH-p62-SBP-EGFP
and pCDH-SBP-EGFP-LC3.
To generate hook plasmids, NLS3 was removed from
pStreptavidin-NLS321 by site-directed mutagenesis with
Agilent QuikChange Lightning according to manu-
facturer’s instructions (primers 5′-GTCGCGGCCGC
TTAGTTGTACAGCTGCTG-3′ and 5′-CAGCAGCTG-
TACA-ACTAAGCGGCCGCGAC-3′), and annealed oli-
gos 5′-GTACAACGCGGCCGCACTGGCG-CGCCAT-3′
and 5′-GGCCATGGCGCGCCAGTGCGGCCGCGTT-3′
were inserted between BsrGI and NotI restriction sites,
yielding pStreptavidin-BsrGI-NotI-AscI. CD74 (primers
5′-TAAGCGGCCGCGATGGACGATCAGAGGGAC-3′
and 5′-TAAGGCGCGCCGATCCTC-ACATGGGGACT
GG-3′) and Golgin84 (primers 5′-TAGCGGCCGCAC
CTTCTTGGTTT-GTTGATCT-3′ and 5′-TAGGCGCG
CCTCATTTGCCATATGGTTGGTCG-3′) were ampli-
ﬁed from human osteosarcoma U2OS cell line genomic
DNA, and subsequently inserted with NotI/AscI into
pStreptavidin–BsrGI–NotI–AscI, yielding pStreptavidin–
CD74 and pStreptavidin–Golgin84.
For all PCRs Phusion DNA Polymerase (NEB, Ipswich,
MA, USA) was used according to manufacturer’s
instructions. Restriction enzymes used were from NEB.
Stable transfection and transduction
U2OS cells were co-transfected with reporter and hook
plasmids using Fugene HD according to manufacturer’s
instructions, followed by 2 weeks selection in neomycin
(0.5 mg/ml) plus hygromycin (100 µg/ml). Clonal lines
Loos et al. Cell Death and Disease          (2019) 10:771 Page 8 of 10
Ofﬁcial journal of the Cell Death Differentiation Association
were established by single cell-sorting on a FACS ARIA III
cytoﬂuorometer (Becton Dickinson, San José, CA, USA),
and subsequently selected for colocalization of streptavi-
din and CALR/B4GALT1 immunoﬂuorescence staining
signal.
LentiBrite™ RFP–LC3 Lentiviral Biosensor viral particles
(Merck Millipore, Burlington, MA, USA) were used for
transduction according to manufacturer’s instructions,
and pools of RFP-positive cells were sorted after 48 h with
a FACS ARIA III cytoﬂuorometer.
Western blotting assay
Cells were washed twice with ice-cold phosphate-buf-
fered saline (PBS) and whole-cell lysates were prepared by
overnight incubation at 4 °C in radioimmunoprecipitation
assay buffer containing protease inhibitor cocktail (Roche,
Basel, Switzerland), followed by centrifugation to remove
insoluble material. The concentrations of total proteins
were measured with a bicinchoninic acid protein assay kit
(Thermo Fisher Scientiﬁc). For Western blot, 30 µg of
protein was resolved on sodium dodecyl sulfate poly-
acrylamide gel electrophoresis gel (Invitrogen) and
transferred to polyvinylidene diﬂuoride membranes
(Merck Millipore). Membranes were blocked in TBS
containing 0.01% Tween-20 and 5% nonfat dry milk for
1 h, and incubated with primary antibody in TBST con-
taining 1% bovine serum albumin (BSA) overnight at 4 °C
on a rocking shaker. Membranes were then washed ﬁve
times with TBST for 10min each, followed by incubation
with secondary antibody for 1 h in TBST containing 1%
BSA. After ﬁve additional washes in TBST for 10 min
each, peroxidase activity was visualized with Amersham
ECL Prime Western Blotting Detection Reagent (GE
Healthcare, Chicago, Il, USA). Dilutions of primary anti-
bodies were 1:10,000 for anti-GAPDH, 1:1000 for
anti-B4GALT1 and 1:1000 for anti-CALR, secondary
antibodies were diluted 1:5000.
Immunoﬂuorescence staining
Cells were seeded into 96- or 384-well black micro-
plates. Following treatment cells were washed once with
PBS, ﬁxed with 4% PFA which containing 1 µg/mL
Hoechst 33342 for 20 min at room temperature and
washed three times with PBS. Cells were then simul-
taneously permeabilized and blocked with 0.1% Triton-
X100 and 5% BSA in PBS for 20 min. Cells were incu-
bated overnight at 4 °C with primary antibodies, washed
three times with PBS, and subsequently incubated with
secondary antibodies for 45 min at room temperature.
After three additional washing steps the plates were
subjected to automated image acquisition and sub-
sequent image analysis as described below. Dilutions of
primary antibodies were 1:250 for rabbit anti-CALR,
1:250 for rabbit B4GALT1, 1:200 for mouse anti-
LAMP1, 1:100 for mouse anti-Streptavidin, and 1:100
for mouse anti-SQSTM1.
Automated and confocal microscopy
For automated ﬂuorescence microscopy, a Molecular
Devices IXM XS BioImager (Molecular Devices, Sunny-
vale, CA, USA) equipped with a Sola light source
(Lumencor, Beaverton, OR, USA), adequate excitation
and emission ﬁlters (Semrock, Rochester, NY, USA), a 16-
bit monochrome sCMOS PCO.edge 5.5 camera (PCO,
Kelheim, Germany), and a 20× PlanAPO objective (Nikon,
Tokyo, Japan) was used to acquire at least four view ﬁelds
for each well. Following acquisition, images were pro-
cessed with the MetaXpress software (Molecular Devices).
For confocal microscopy a confocal laser scanning
microscope ZEISS LSM710 (Carl Zeiss, Jena, Germany)
equipped with Zeiss plan-Apochromat 63×/1.4 oil
immersion objective was used to acquire images with
lasers of wavelengths 405, 488, and 633 nm. Images were
processed using the freely available software ImageJ
(https://imagej.net).
Statistical analyses
Unless otherwise speciﬁed, data are reported as mean ±
standard deviation of a minimum of three independent
experiments. Standard deviation was calculated as
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
P
xxð Þ2
n
q
, where x is the sample mean and n is the
sample size. Statistical signiﬁcance was analyzed using
Student’s t test. Differences to indicated control cells were
considered to be signiﬁcant if p < 0.05 (*/#), p < 0.01
(**/##), or p < 0.001 (***/###). Surface overlap coefﬁcient
was calculated as described elsewhere36.
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